Home › Products › Oncology › Erleva 150mg Tablet
Erleva 150mg Tablet
Salt Composition: ERLOTINIB
- Manufacturer: GLENMARK PHARMACEUTICALS LTD
- Pack Size: 30 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Keep out of sight and reach of children. Store at a controlled room temperature between 15°C to 30°C. Do not freeze.
₹4313.00₹5390.63
Inclusive of all taxes
Product Introduction
Erleva 150 mg Tablet is an anticancer medicine used to treat advanced or metastatic non-small cell lung cancer. In combination with Gemcitabine, it is also used for patients with metastatic pancreatic cancer. Cancer involves abnormal and uncontrolled multiplication of cells within the body.
Administration of this medicine may lead to kidney and liver failure. Your doctor will periodically monitor kidney and liver function during treatment.
Inform your physician about any history of clotting disorders or any medicines you take for clotting disorders, as Erleva 150 mg Tablet may increase the tendency to bleed.
Contact your doctor if you develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, or persistent diarrhoea while taking this medicine.
Do not smoke while being treated with this medicine, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside.
Uses
Advanced or metastatic non-small lung cancer (NSCLC) Advanced or metastatic pancreatic cancer
How it works
Erleva 150 mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
How to Use
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food. Contact the doctor if any missed dose or taken more.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Persistent or severe diarrhea Pain in the eye, blurred vision sudden difficulty in breathing accompanied by cough and fever severe pain in your abdomen liver failure Common: Rash, worsened in sun-exposed areas Loss of appetite decreased weight Infection Headache, changes in skin sensation Depression Nausea Mouth irritation Indigestion, stomach pain, the buildup of gas Hair loss, dry skin, itching Tiredness, fever, abnormal liver function Inflammation around fingernail acne, cracked skin bleeding from the nose, stomach, intestines reduced kidney function
Expert Tips
Inform the doctor if the patient has vision problems, use of contact lenses, clotting disorders, intolerance to sugar, and medication is taken for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney and liver disorders, as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737
- Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
- Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf
Safety Advice
Pregnancy: Consult your doctor Taking Erleva 150 mg Tablet while pregnancy can harm the baby. Patients should not take this medicine during pregnancy unless the doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Lungs: unsafe This medicine is not recommended in patients with severe lung diseases. Inform the physician if the patient has any lung disorders.
Breastfeeding: unsafe You must not take an Erleva 150 mg Tablet if the patients are breastfeeding. Consult the doctor for risks and benefits.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.